TX-SCHUMACHER-ELECTRIC
Schumacher Electric Corporation, the global leader of automotive aftermarket power conversion products, has introduced its new Rugged Lithium Ion Jump Starter series to the United States and European markets. Available in 1000, 1500, 2000 and 2500 peak amps, these jump starters are powerful, portable and compact, and can safely start a dead battery in seconds. The line will be available online and in select retailers.
“Our national lithium jump starter launch times perfectly for winterization preparations as the jump starters feature pre-heating technology to warm batteries in extreme cold,” said Mickey Leech, CEO at Schumacher Electric Corporation. “It’s also the perfect holiday gift for all drivers in your family or simply the person who has it all because of its multi-use design that includes the ability to charge a variety of USB devices. As we move towards our 75th company anniversary in 2022, we will continue to bring new, innovative products to market and set Schumacher apart from its competitors.”
Key features of the Schumacher Rugged Lithium Ion Jump Starter Product Line:
Schumacher 1000 Peak Amp Rugged Lithium Ion Jump Starter
- 1000 peak amps
- 25 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 6.0L gas and 3.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 1500 Peak Amp Rugged Lithium Ion Jump Starter
- 1500 peak amps
- 35 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 8.0L gas and 6.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2000 Peak Amp Rugged Lithium Ion Jump Starter
- 2000 peak amps
- 45 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2500 Peak Amp Rugged Lithium Ion Jump Starter
- 2500 peak amps
- 50 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster
- 2.4A USB charges devices twice as fast via powered USB port
- LED area light
“We are pleased to bring top-of-the-line lithium jump starter products to market that are not only powerful but designed with ease-of-use in mind,” said Dirk Kuyckx, general manager of Schumacher Europe. “We wanted to offer a variety of products with unique features to meet the needs of all consumers and standout in a crowded market. Whether it’s a car, van, SUV, boat or recreational vehicle, our lithium jump starter has a durable rugged design with pre-boost technology for bringing even deeply discharged batteries back to life.”
About Schumacher Electric Corporation
Schumacher Electric Corporation is known for industry-leading innovation, an unwavering commitment to quality, and providing feature-rich products that represent a remarkable value and price. For nearly 75 years, Schumacher has been powering lifestyles with a legacy centered on delivering product excellence and exceptional service to customers with a broad range of needs and experience levels. Put your trust in a Schumacher.
To learn more visit: www.schumacherelectric.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005155/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 08:00:00 CET | Press release
Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January 14-17 2026 in Madrid, Spain. Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.”
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom